Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Selectis Health (GBCS) Income towards Parent Company (2017 - 2025)

Selectis Health's Income towards Parent Company history spans 14 years, with the latest figure at -$1.1 million for Q4 2025.

  • Quarterly results put Income towards Parent Company at -$1.1 million for Q4 2025, down 164.94% from a year ago — trailing twelve months through Dec 2025 was -$3.3 million (down 28.76% YoY), and the annual figure for FY2025 was -$1.0 million, up 58.1%.
  • Income towards Parent Company for Q4 2025 was -$1.1 million at Selectis Health, down from -$502660.0 in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $1.8 million in Q4 2024 to a low of -$3.7 million in Q4 2023.
  • The 5-year median for Income towards Parent Company is -$1.1 million (2022), against an average of -$1.1 million.
  • The sharpest move saw Income towards Parent Company tumbled 1451.62% in 2021, then skyrocketed 252.37% in 2022.
  • Year by year, Income towards Parent Company stood at -$2.0 million in 2021, then fell by 12.4% to -$2.2 million in 2022, then plummeted by 65.07% to -$3.7 million in 2023, then surged by 148.11% to $1.8 million in 2024, then crashed by 164.94% to -$1.1 million in 2025.
  • According to Business Quant data, Income towards Parent Company over the past three periods came in at -$1.1 million, -$502660.0, and -$676280.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.